Reduced Worries of Hypoglycaemia, High Satisfaction, and Increased Perceived Ease of Use after Experiencing Four Nights of MD-Logic Artificial Pancreas at Home (DREAM4)

Table 1

Baseline patient characteristics.

	Children (10–14 yrs); (n = 20)	Adolescents; (14–18 yrs); (n = 20)	Adults; (>18 yrs); (n = 19)	value	Israel; (n = 29)	Slovenia; (n = 15)	Germany; (n = 15)	value	All; (n = 59)
Age (years), mean (SD)	12.3; (1.17)	15.6; (0.86)	31.22; (9.96)		17.45; (6.43)	22.07; (12.00)	20.96; (12.96)	0.286	19.51; (9.98)
Male (%)	50	60	52.6	0.806	55.2	46.7	60.0	0.757	54
HbA1c (%), mean (SD)	7.97; (0.72)	7.93; (0.76)	7.78; (0.58)	0.679	8.03; (0.71)	7.89; (0.74)	7.63; (0.53)	0.184	7.89; (0.69)
HbA1c (mmol/mol, IFCC), mean (SD)	63.50; (7.90)	63.15; (8.33)	61.44; (6.32)		64.17; (7.78)	62.78; (8.13)	59.84; (5.75)		62.72; (7.51)
Diabetes duration (years), mean (SD)	7.25; (3.06)	8.78; (3.31)	19.24; (10.82)	0.000	9.21; (5.42)	13.92; (12.29)	14.03; (7.85)	0.094	11.63; (8.44)
CSII duration (years), mean (SD)	5.68; (3.35)	6.32; (2.82)	8.96; (5.58)	0.036	5.77; (3.52)	7.45; (3.24)	8.74; (5.70)	0.075	6.95; (4.24)
Regular sensor use (%)	65	55	26.3	0.044	62.1	53.3	20.0	0.028	49.2